Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 128 | 68 | 1,090 | 18 | 283 |
| Cost of Goods | 33 | 12 | 862 | 309 | N/A |
| Gross Profit | 95 | 56 | 228 | -291 | 283 |
| Operating Expenses | 1,868 | 1,507 | 2,368 | 1,781 | 2,091 |
| Operating Income | -1,740 | -1,439 | -1,278 | -1,763 | -1,808 |
| Other Income | 604 | -2,011 | 2,057 | 569 | 1,477 |
| Pre-tax Income | -1,136 | -3,450 | 779 | -1,194 | -331 |
| Net Income Continuous | -1,136 | -3,450 | 779 | -1,006 | -331 |
| Net Income | $-1,136 | $-3,450 | $779 | $-1,006 | $-331 |
| EPS Basic Total Ops | -2.00 | -15.00 | 4.00 | -4.00 | -2.00 |
| EPS Basic Continuous Ops | -2.02 | -14.67 | 3.62 | -3.95 | -1.96 |
| EPS Diluted Total Ops | -2.00 | -15.00 | 4.00 | -4.00 | -2.00 |
| EPS Diluted Continuous Ops | -2.02 | -14.67 | 3.56 | -3.90 | -1.96 |
| EBITDA(a) | $-1,716 | $-1,423 | $-1,185 | $-1,722 | $-1,708 |